中国甲银屑病:一项前瞻性多中心研究
该研究在中国25家医院前瞻性纳入817例甲银屑病患者,描述其流行病学、临床表现、真菌感染、关节症状及治疗情况。结果显示指甲受累占95.29%、趾甲占57.18%,13.26%合并甲真菌病,12.17%有关节症状,仅2.30%患者接受治疗。
要点
- 指甲受累率95.29%,趾甲57.18%,点状凹陷和甲下角化过度最常见。
- 13.26%的甲银屑病患者合并甲真菌病,其中77.08%位于趾甲。
- 12.17%患者报告关节症状,且与特定甲改变显著相关。
核心结论
- 甲银屑病在指甲与趾甲表现不同,趾甲合并甲真菌病需特别关注。
- 银屑病患者的关节症状与特定甲改变相关,需研究和倡导更有效的甲银屑病治疗。
研究设计与样本
- 2021年8月至2022年8月在中国25家医院开展的前瞻性多中心观察性研究,纳入817例甲银屑病患者。
主要发现
- 患者平均体质指数为24.13 ± 2.93,71.41%为男性。
- 甲银屑病严重度指数评分与体表面积呈弱正相关。
- 指甲受累百分比为95.29%,趾甲为57.18%,点状凹陷(67.11%)和甲下角化过度(60.40%)分别为最常见表现。
- 趾甲甲周鳞屑、甲下角化过度和甲板碎裂频率显著更高,而裂片形出血、点状凹陷和甲半月红斑频率更低。
- 13.26%的银屑病患者合并甲真菌病,其中77.08%位于趾甲;12.17%报告关节症状,以周围型为主。
关键数值与推荐
- 关节症状与甲周肿胀、甲下角化过度、甲周鳞屑、甲剥离和纵嵴存在显著关联。
- 仅2.30%(871例中20例)的甲银屑病患者接受了治疗;伴甲受累的皮肤银屑病最常用生物制剂治疗(n = 366)。
临床怎么用
- 临床应区分指甲与趾甲银屑病表现,对趾甲病变注意排查甲真菌病。
- 对甲银屑病患者应评估关节症状,并关注甲周肿胀、甲下角化过度等关联体征。
- 甲银屑病治疗率极低,需加强有效治疗的研究与推广。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on nail psoriasis (PsO) in China are scarce. OBJECTIVES: To provide nail PsO-related data regarding epidemiologic characteristics, manifestations, fungal infections, arthritic complaints and treatments that may facilitate improved patient management globally. METHODS: From August 2021 to August 2022, patients with nail PsO were enrolled in a prospective multicentre observational study at 25 hospitals in China. We collected and analysed data concerning nail PsO demography, clinical signs, fungal detection, arthritic symptoms and treatment. RESULTS: A total of 817 patients with nail PsO were involved, with a mean body mass index of 24.13 ± 2.93. In addition, 71.41% of the patients were male. The Nail PsO Severity Index score was weakly positively correlated with body surface area. The percentage of nail involvement was 95.29% for fingernails and 57.18% for toenails, with pitting (67.11%) and subungual hyperkeratosis (60.40%) being the most prevalent manifestations, respectively. Toenails showed a significantly higher frequency of nailfold scales, subungual hyperkeratosis and nail plate crumbling and a lower frequency of splinter haemorrhages, pitting and erythema of the lunula. A total of 13.26% of the PsO patients had onychomycosis, and 77.08% were observed in the toenails. Articular symptoms were reported by 12.17% of the patients, with the peripheral type being predominant. Significant associations between articular symptoms and nailfold swelling, subungual hyperkeratosis, nailfold scales, onycholysis and longitudinal ridges were found. Only 2.30% (20 out of 871) of patients with nail PsO received treatment. The most frequently employed therapy for cutaneous PsO with nail involvement was biologic therapy (n = 366). CONCLUSIONS: PsO showed distinct manifestations in the toenails and fingernails. Additionally, toenail PsO combined with onychomycosis requires special attention. Articular symptoms in psoriatic patients are associated with specific nail changes. It is important to research and advocate for more potent treatments for nail PsO.
引用
- Wang S, Zhu J, Wang P, et al. Nail psoriasis in China: A prospective multicentre study. J Eur Acad Dermatol Venereol. 2023. PMID: 38100231. doi:10.1111/jdv.19684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。